Plain-English translation of NCT07718815 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand why psoriatic arthritis develops in some people. This study compares genetic material from people who have psoriatic arthritis to healthy volunteers without any inflammatory diseases. By looking at a specific genetic marker called HLA B leader, scientists hope to learn more about what causes this condition.
Psoriatic arthritis is a chronic disease that causes joint pain and inflammation in people who have psoriasis. Scientists know that certain genetic factors increase the risk of developing this disease, but they don't yet fully understand how a genetic marker called HLA B leader might be involved.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate a blood sample that researchers will test for genetic markers. The study compares genetic information from people with psoriatic arthritis to healthy volunteers without inflammatory diseases. Participation is one-time and non-invasive—just a single blood draw.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
France
Centre Hospitalier Universitaire, Amiens
Enrollment target
~658 participants
Started
May 2025
Primary completion
September 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Vincent Goeb, Pr
Centre Hospitalier Universitaire, Amiens
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.